9 Feb 2023 Fagron reports 19% topline growth, 11% increase in REBITDA and free cash flow of €91 million for 2022 Download
19 Dec 2022 Disclosure of notifications received from Active Ownership Corporation S.à r.l. and from AOC Pharma S.à r.l. Download
27 Sep 2022 Fagron launches excipients line DiluCap – making capsule formulation easier and more reliable Download